Zummo Jacqueline (CIK 1798929) reported 8 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-04-09). Recent activity: Sell TARA (1,134 shares), Sell TARA (22,598 shares), Sell TARA (3,724 shares), Sell TARA (6,578 shares), Buy TARA (30,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-09 | Protara Therapeutics, Inc. (TARA) | Chief R&D Officer | Sell | 1,134 | $6,124 |
| 2026-04-02 | Protara Therapeutics, Inc. (TARA) | Chief R&D Officer | Sell | 22,598 | $118,865 |
| 2026-01-27 | Protara Therapeutics, Inc. (TARA) | Chf Scientific Operations Off | Sell | 3,724 | $24,839 |
| 2026-01-22 | Protara Therapeutics, Inc. (TARA) | Chf Scientific Operations Off | Sell | 6,578 | $36,837 |
| 2026-01-21 | Protara Therapeutics, Inc. (TARA) | Chf Scientific Operations Off | Buy | 30,000 | $0 |
| 2025-03-28 | Protara Therapeutics, Inc. (TARA) | Chf Scientific Operations Off | Sell | 21,224 | $96,145 |
| 2025-01-28 | Protara Therapeutics, Inc. (TARA) | Chf Scientific Operations Off | Buy | 24,500 | $0 |
| 2025-01-23 | Protara Therapeutics, Inc. (TARA) | Chf Scientific Operations Off | Sell | 6,554 | $31,197 |
Source: SEC Form 4 filings · as of 2026-04-09